Cao LQ - Search Results

1

Nivolumab and relatlimab for the treatment of melanoma.

Chen XY, Li YD, Xie Y, Cao LQ, Ashby CR Jr, Zhao H, Chen ZS. Chen XY, et al. Among authors: cao lq. Drugs Today (Barc). 2023 Feb;59(2):91-104. doi: 10.1358/dot.2023.59.2.3509756. Drugs Today (Barc). 2023. PMID: 36811409 Review.

2

A cycloruthenated complex, ruthenium (II) Z (RuZ) overcomes in vitro and in vivo multidrug resistance in cancer cells: A pivotal breakthrough.

Cao L, Xie Y, Chen Z, Ashby CR. Cao L, et al. J Transl Int Med. 2023 Jul 5;11(2):95-97. doi: 10.2478/jtim-2023-0081. eCollection 2023 Jul. J Transl Int Med. 2023. PMID: 37408573 Free PMC article. No abstract available.

3

The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond.

Chen DQ, Xie Y, Cao LQ, Fleishman JS, Chen Y, Wu T, Yang DH. Chen DQ, et al. Among authors: cao lq. Drug Resist Updat. 2024 Mar;73:101062. doi: 10.1016/j.drup.2024.101062. Epub 2024 Jan 29. Drug Resist Updat. 2024. PMID: 38330827 Review.

4

[Role and progress of allogeneic hematopoietic stem cell transplantation in the treatment of refractory/relapsed diffuse large B-cell lymphoma].

Cao LQ, Mo XD. Cao LQ, et al. Zhonghua Xue Ye Xue Za Zhi. 2024 Mar 14;45(3):308-312. doi: 10.3760/cma.j.cn121090-20231017-00213. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 38716606 Review. Chinese.

5

Male reproductive function before and after the adjustment of the COVID-19 prevention policy: a multicenter study in China.

Li JZ, Wu H, Wang L, Wang YS, Kong F, Cao LQ, Liang M, Wang X, Yuan MZ. Li JZ, et al. Among authors: cao lq. Asian J Androl. 2024 Apr 19. doi: 10.4103/aja202388. Online ahead of print. Asian J Androl. 2024. PMID: 38639721 Free article.

6

Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy.

Cao LQ, Sun H, Xie Y, Patel H, Bo L, Lin H, Chen ZS. Cao LQ, et al. Front Pharmacol. 2024 Jan 24;15:1340764. doi: 10.3389/fphar.2024.1340764. eCollection 2024. Front Pharmacol. 2024. PMID: 38327984 Free PMC article. Review.

7

[Current status and prospects of hematopoietic stem cell transplantation in peripheral T-cell lymphoma].

Cao LQ, Huang XJ, Mo XD. Cao LQ, et al. Zhonghua Nei Ke Za Zhi. 2023 Dec 1;62(12):1489-1493. doi: 10.3760/cma.j.cn112138-20230417-00200. Zhonghua Nei Ke Za Zhi. 2023. PMID: 38044079 Chinese.

8

Peripheral blood stem cell transplantation from haploidentical related donor could achieve satisfactory clinical outcomes for intermediate- or high-risk adult acute myeloid leukemia patients.

Cao LQ, Huo WX, Zhang XH, Xu LP, Wang Y, Yan CH, Chen H, Chen YH, Han W, Wang FR, Wang JZ, Huang XJ, Mo XD. Cao LQ, et al. Bone Marrow Transplant. 2024 Feb;59(2):203-210. doi: 10.1038/s41409-023-02117-x. Epub 2023 Nov 15. Bone Marrow Transplant. 2024. PMID: 37968447

9

[Comparative study of two novel nickel-titanium instruments for root canal preparation in curved canals on shaping ability and microcrack formation].

Feng F, Cao LQ, Zhang Q. Feng F, et al. Among authors: cao lq. Shanghai Kou Qiang Yi Xue. 2023 Jun;32(3):225-229. Shanghai Kou Qiang Yi Xue. 2023. PMID: 37803973 Chinese.

10

Advances and perspectives on the research of starfish outbreaks in northern China.

Wang Y, Gu YB, Guo H, Cao LQ, Jin Y. Wang Y, et al. Among authors: cao lq. Ying Yong Sheng Tai Xue Bao. 2023 Apr;34(4):1146-1152. doi: 10.13287/j.1001-9332.202304.031. Ying Yong Sheng Tai Xue Bao. 2023. PMID: 37078336 English.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page